Garmestani K - Search Results

1

Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.

Zhang M, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Brechbiel MW, Carrasquillo JA, Waldmann TA. Zhang M, et al. Among authors: garmestani k. Cancer Res. 2004 Aug 15;64(16):5825-9. doi: 10.1158/0008-5472.CAN-04-1088. Cancer Res. 2004. PMID: 15313926

2

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.

Zhang M, Yao Z, Garmestani K, Axworthy DB, Zhang Z, Mallett RW, Theodore LJ, Goldman CK, Brechbiel MW, Carrasquillo JA, Waldmann TA. Zhang M, et al. Among authors: garmestani k. Blood. 2002 Jul 1;100(1):208-16. doi: 10.1182/blood-2002-01-0107. Blood. 2002. PMID: 12070029 Free article.

3

Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin.

Yao Z, Zhang M, Axworthy DB, Wong KJ, Garmestani K, Park L, Park CW, Mallett RW, Theodore LJ, Yau EK, Waldmann TA, Brechbiel MW, Paik CH, Pastan I, Carrasquillo JA. Yao Z, et al. Among authors: garmestani k. Cancer Res. 2002 Oct 15;62(20):5755-60. Cancer Res. 2002. PMID: 12384535

4

Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.

Zhang M, Zhang Z, Garmestani K, Schultz J, Axworthy DB, Goldman CK, Brechbiel MW, Carrasquillo JA, Waldmann TA. Zhang M, et al. Among authors: garmestani k. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1891-5. doi: 10.1073/pnas.0437788100. Epub 2003 Feb 4. Proc Natl Acad Sci U S A. 2003. PMID: 12569172 Free PMC article.

5

Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotin.

Yao Z, Zhang M, Garmestani K, Axworthy DB, Mallett RW, Fritzberg AR, Theodore LJ, Plascjak PS, Eckelman WC, Waldmann TA, Pastan I, Paik CH, Brechbiel MW, Carrasquillo JA. Yao Z, et al. Among authors: garmestani k. Clin Cancer Res. 2004 May 1;10(9):3137-46. doi: 10.1158/1078-0432.ccr-03-0171. Clin Cancer Res. 2004. PMID: 15131055

6

Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.

Zhang M, Yao Z, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Janik J, Brechbiel MW, Waldmann TA. Zhang M, et al. Among authors: garmestani k. Blood. 2006 Jul 15;108(2):705-10. doi: 10.1182/blood-2005-11-4607. Epub 2006 Mar 21. Blood. 2006. PMID: 16551968 Free PMC article.

7

Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25.

Zhang Z, Zhang M, Garmestani K, Talanov VS, Plascjak PS, Beck B, Goldman C, Brechbiel MW, Waldmann TA. Zhang Z, et al. Among authors: garmestani k. Blood. 2006 Aug 1;108(3):1007-12. doi: 10.1182/blood-2005-11-4757. Epub 2006 Mar 28. Blood. 2006. PMID: 16569769 Free PMC article.

8

The anti-CD25 monoclonal antibody 7G7/B6, armed with the alpha-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia.

Zhang M, Yao Z, Zhang Z, Garmestani K, Talanov VS, Plascjak PS, Yu S, Kim HS, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA. Zhang M, et al. Among authors: garmestani k. Cancer Res. 2006 Aug 15;66(16):8227-32. doi: 10.1158/0008-5472.CAN-06-1189. Cancer Res. 2006. PMID: 16912202

9

Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1.

Zhang M, Yao Z, Patel H, Garmestani K, Zhang Z, Talanov VS, Plascjak PS, Goldman CK, Janik JE, Brechbiel MW, Waldmann TA. Zhang M, et al. Among authors: garmestani k. Proc Natl Acad Sci U S A. 2007 May 15;104(20):8444-8. doi: 10.1073/pnas.0702496104. Epub 2007 May 8. Proc Natl Acad Sci U S A. 2007. PMID: 17488826 Free PMC article.

10

Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma.

Zhang M, Yao Z, Garmestani K, Yu S, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA. Zhang M, et al. Among authors: garmestani k. Cancer Biother Radiopharm. 2009 Jun;24(3):303-9. doi: 10.1089/cbr.2008.0577. Cancer Biother Radiopharm. 2009. PMID: 19538052 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters